Pharma
Contacts & Partnering Print PDF

 

Biological Research 

For more information on Hybrigenics’ programs, research platforms and partnering possibilities please contact: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

 

 

Research and Clinical Development of Inecalcitol 

For more information on Resaerch and Clinical Development  as well as partnering possibilities please contact: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

or download the Inecalcitol information sheet  

 

Hybrigenics starts phase 2 trial, Inecalcitol-CT2 , in hormone-refractory prostate cancer .

The first patient has been treated in France on November 7, 2007 at the European Hospital Georges Pompidou in Paris.
© 2008 hybrigenics